Milind Desai, MD, MBA

Appointed
2005

Education & Fellowships

Graduate School - University of Tennessee Haslam College of Business
Enrollment only
Knoxville, TN
2020

Fellowship - Johns Hopkins University School of Medicine
Cardiovascular Disease
Baltimore, MD
2004

Fellowship - Allegheny General Hospital-Suburban Campus
Cardiovascular Disease
Pittsburgh, PA
2003

Fellowship - Brigham & Women's Hospital
Nuclear Cardiology
Boston, MA
2001

Residency - Southern Illinois University School of Medicine
Internal Medicine
Springfield, IL
1997

Medical Education - N.H.L. Municipal Medical College, Gujarat University
MD
Ahmedabad, Gujarat, India
1994

Additional Training

Professional Highlights

Certifications

• Cardiovascular Computed Tomography
• Internal Medicine - Cardiovascular Disease

Specialty Interests

Heart valve disease, hypertrophic cardiomyopathy, aortic disorders, complex coronary artery disease, pericardial disease, pericarditis, radiation heart disease. Dr. Desai has special interest in multimodality cardiovascular imaging, including echocardiogram, computed tomography (CT) scan and magnetic resonance imaging (MRI)

Awards & Honors

• FACC

Innovations & Patents

Memberships

• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Society of Cardiac Magnetic Resonance
• Society of Cardiac Computed Tomography
• American Society of Echocardiography
• American Society of Nuclear Cardiology
• European Society of Cardiology (ESC).

  Dr. Desai has been nominated as a fellow by the ACC, AHA and ESC

See publications for Milind Desai, MD, MBA.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/18/2024, Dr. Desai has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Desai receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Bristol-Myers Squibb
• Tenaya Therapeutics, Inc.
• LianBio

Donation of Financial Interest. Dr. Desai has consulted for, received compensation for serving as a fiduciary from, or received royalties from the following companies but instructed them to donate all compensation to not-for-profit causes or to the Cleveland Clinic to support research and education:

• Caristo Diagnostics
• Cytokinetics, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.